| Entry |
|
|---|
| Name |
Prochlorperazine mesilate (JAN);
Prochlorperazine dimethanesulfonate;
Novamin (TN) |
|---|
| Formula |
C20H24ClN3S. (CH4SO3)2
|
|---|
| Exact mass |
565.1142
|
|---|
| Mol weight |
566.154
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Neuropsychiatric agent
DG01478 Dopamine antagonist
DG01474 Dopamine D2-receptor antagonist
DG03200 Antipsychotic agent
DG01905 Phenothiazine antipsychotics
|
|---|
| Remark |
| Therapeutic category: | 1172 |
| Product (DG00876): | D00493<US> D00479<JP/US> D02022<JP> D02609<US> |
|
|---|
| Efficacy |
Antipsychotic, Dopamine D2 receptor antagonist |
|---|
| Comment |
Phenothiazine derivative
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Structure map |
| map07029 | Antipsychotics - phenothiazines |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N05 PSYCHOLEPTICS
N05A ANTIPSYCHOTICS
N05AB Phenothiazines with piperazine structure
N05AB04 Prochlorperazine
D02022 Prochlorperazine mesilate (JAN) <JP>
USP drug classification [BR:br08302]
Antiemetics
Antiemetics, Other
Prochlorperazine
D02022 Prochlorperazine mesilate (JAN)
Antipsychotics
1st Generation/Typical
Prochlorperazine
D02022 Prochlorperazine mesilate (JAN)
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
11 Agents affecting central nervous system
117 Psychotropics
1172 Phenothiazines
D02022 Prochlorperazine mesilate (JAN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01478 Dopamine antagonist
DG01474 Dopamine D2-receptor antagonist
DG00876 Prochlorperazine
D02022 Prochlorperazine mesilate
DG03200 Antipsychotic agent
DG01905 Phenothiazine antipsychotics
DG00876 Prochlorperazine
D02022 Prochlorperazine mesilate
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Dopamine
DRD2
D02022 Prochlorperazine mesilate (JAN) <JP>
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01478 Dopamine antagonist
DG01474 Dopamine D2-receptor antagonist
DG00876 Prochlorperazine
DG03200 Antipsychotic agent
DG01905 Phenothiazine antipsychotics
DG00876 Prochlorperazine
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 35
1 S4a S 37.7980 -17.9935
2 C1a C 36.4023 -17.9935
3 O1d O 39.1937 -17.9935
4 O1d O 37.7908 -16.5978
5 O1d O 37.7908 -19.3893
6 C8x C 23.0300 -18.0600
7 C8x C 23.0300 -19.4600
8 C8x C 24.2200 -20.1600
9 C8y C 25.4800 -19.4600
10 C8y C 25.4800 -18.0600
11 C8x C 24.2200 -17.3600
12 S2x S 26.6700 -20.1600
13 C8y C 27.8600 -19.4600
14 C8y C 27.8600 -18.0600
15 N4y N 26.6700 -17.3600
16 C8x C 29.1200 -20.1600
17 C8x C 30.3100 -19.4600
18 C8y C 30.3100 -18.0600
19 C8x C 29.1200 -17.3600
20 C1b C 26.6700 -15.9600
21 X Cl 31.5000 -17.3600
22 C1b C 27.8600 -15.2600
23 C1b C 29.0500 -15.9600
24 N1y N 30.2400 -15.2600
25 C1x C 31.4300 -15.9600
26 C1x C 32.6900 -15.2600
27 N1y N 32.6900 -13.8600
28 C1x C 31.5000 -13.1600
29 C1x C 30.2400 -13.8600
30 C1a C 33.8800 -13.1600
31 S4a S 37.7980 -17.9935
32 C1a C 36.4023 -17.9935
33 O1d O 39.1937 -17.9935
34 O1d O 37.7908 -16.5978
35 O1d O 37.7908 -19.3893
BOND 36
1 6 7 2
2 7 8 1
3 8 9 2
4 9 10 1
5 10 11 2
6 6 11 1
7 9 12 1
8 12 13 1
9 13 14 1
10 14 15 1
11 10 15 1
12 13 16 2
13 16 17 1
14 17 18 2
15 18 19 1
16 14 19 2
17 15 20 1
18 18 21 1
19 20 22 1
20 22 23 1
21 23 24 1
22 24 25 1
23 25 26 1
24 26 27 1
25 27 28 1
26 28 29 1
27 24 29 1
28 27 30 1
29 1 2 1
30 1 3 1
31 1 4 2
32 1 5 2
33 31 32 1
34 31 33 1
35 31 34 2
36 31 35 2
BRACKET 1 34.3700 -20.3700 34.3700 -15.5400
1 40.7400 -15.5400 40.7400 -20.3700
1 2
ORIGINAL 1 1 2 3 4 5
REPEAT 1 31 32 33 34 35
|
|---|
